Events
Previous EventsContact person
MVA’s calendar provides you with an overview of life science events and courses taking place in Medicon Valley. To stay updated on life science events and courses relevant for you and your colleagues, sign up for the bi-weekly newsletter MVA Update which lists all upcoming events and courses or subscribe to our Event RSS Feed.
Medicon Valley Alliance and Syneos are pleased to invite you to a Good Morning Meeting on the 13th of March in Copenhagen focusing on: Navigating the current funding environment and other key challenges in drug development for 2024 and beyond. An overview of the recent dynamic environmental, economic, regulatory and payer developments which are creating […]
Read moreMedicon Valley Alliance and Labcorp would like to welcome you to an exploration of New Approach Methodologies (NAMs) and their impact on diverse scientific realms. From in vitro alternatives to non-animal methods, NAMs have evolved into an internationally accepted term with industry-agnostic applications. Our sessions will unravel the regulatory landscape, delve into innovative seizure liability […]
Read moreThe workshop aims to familiarise clinical researchers with HALRIC by providing an insight into the pilot project programme, the partner institutions, and the various infrastructure offerings within the consortium. Additionally, the workshop will include presentations of application examples in 3D imaging and immune cell tracking. Date: 7 March, 2024 Time: 17.00 – 18.30 Venue: Hamburg […]
Read moreMedicon Valley Alliance invites you to join this network meeting on Women in clinical trials. Women are underrepresented in clinical studies – especially in phase I trials were only 29 – 34 % of participants in Phase I trials are female. And 74 % of clinical trials do not report outcome by sex. But why […]
Read moreThis interactive workshop aims to guide researchers in crafting impactful visualizations that enhance comprehension and communication of complex findings. The workshop encourages active participation from researchers interested in refining their skills and staying up to date with the latest advancements in visualization technologies. By the end of the event, participants will gain practical insights, enabling […]
Read moreMedicon Valley Alliance and PharmaLex are pleased to invite you to a Good Morning Meeting on the 23rd of January in Copenhagen focusing on: How to successfully address non-conformances raised by your Notified Body? Key learnings for the medical device manufacturers and to the Notified Body Opinion (NBOp) applicants Topics will include: Typical Notified […]
Read moreMeet both new and familiar faces from EU´s largest life science cluster and get your 2024 networking started. Having closed another packed and outstanding year in Medicon Valley with a lot of networking, events and great projects’ start, we look forward to yet another eventful 2024. You are hereby invited to join us in welcoming […]
Read moreAll projects are different, but a number of parameters are consistent in addition to the guidelines/requirements from ICH, FDA, EMA. Selected characteristics of Small Molecule development projects will be discussed. Highlighting topics concerning: Management of risk and investment Optimization and adaptation of MedChem procedures towards manufacturing Sustainability Introduction of green(-er) chemistry Cost of waste management […]
Read moreJoin us to gain a greater understanding of the cancer patient journey as our speakers discuss early phase trial design along with optimal data collection and endpoint analysis. You’ll also hear about applying the right digital solutions to balance the needs of the patient, optimizing recruitment and retention and expediting key decision-making. This symposium unites […]
Read moreThe introduction of IVDR and MDR, in European Union, brought considerably increased regulatory expectations especially in the area of clinical evidence for the industry. Those changes found the industry intrinsically unprepared and lagging the initiative driven approach needed to close the regulatory gaps generated. The state of Clinical Evaluation, PMCF activities and ultimately clinical evidence […]
Read moreATMPs (cell and gene therapies) have the potential to cure currently uncurable diseases by replacing dead or injured cells or broken genes. Remarkable data is presented worldwide from first clinical trials where patients have been cured. The development of these advanced therapies needs novel ways for collaboration between academia, health care and industry for accelerating […]
Read moreWhile much research has focused on the gut microbiome, there is growing interest and recognition that microbiomes in other parts of the body also play crucial roles in human health. At the MVA Microbiome Network meeting we will look into the future of health innovations mediated by the gut, skin, vaginal, and oral microbiomes. The […]
Read moreBuilding upon the insights shared during our Science for Breakfast event on November 14, Saromics Biostructures and SmiLe Incubator will delve deeper into the significance of research infrastructures like MAX IV, DESY, ESS, and European XFEL. They will be detailing their current applications and sharing their industrial experiences during this Science for Lunch session. The […]
Read moreUnleashing the Medicon Valley potential Join us at the MVA Annual Summit 2023 for a day focused on unlocking the vast potential of Medicon Valley. This event will bring together industry leaders, researchers, and experts to explore the latest advancements and opportunities in the vibrant Medicon Valley region. Don’t miss out on this opportunity to […]
Read moreMedicon Valley Alliance and AbbVie are pleased to invite you to an Abbvie Partnering Day on the 26th of October in Copenhagen. At AbbVie, we partner to achieve two important outcomes: deliver innovative medicines and make a remarkable impact on people’s lives. AbbVie’s Partnering Days provide an opportunity to access senior level Corporate Business Strategy […]
Read moreBridging oral and systemic health For the second year in a row, Medicon Valley Alliance is happy to invite you all to “Dent2Health 2023”, a conference with focus on bridging oral and systemic health. Oral biomarkers, oral screening, and health promotion are some of the topics that will be highlighted during this day. Participants will […]
Read moreWe invite you to join us for a breakfast meeting centered around the crucial topic of Sponsor oversight for clinical trials, that are partly or fully outsourced to a Contract Research Organizations (CROs). This meeting aims to explore and elucidate the best practices and strategies for ensuring effective oversight in such Sponsor-CRO collaborations. As the […]
Read moreMedicon Valley Alliance and Genscript ProBio are pleased to invite you to a Good Morning Meeting on the 5th of October in Copenhagen focusing on accelerated ADC development via integrated antibody discovery platform. Key learning objectives: Brief overview of history and current trending of antibody-drug conjugates Tools and strategies for ADC naked antibody discovery & […]
Read moreMedicon Valley Alliance and IQVIA are pleased to invite you to a Good Morning Meeting on the 4th of October in Copenhagen focusing on how to create value for biotech companies through reducing risk, time to market and optimizing peak sales. Early stage biotech companies need to fill the evidence gaps at their stage of […]
Read moreMedicon Valley Alliance in Collaboration with BII invites you to join this network meeting on Endometriosis. Endometriosis is a common yet poorly understood condition. Around 10 % of all women in the reproductive age suffer from endometriosis -and yet it takes on average 7,5 years from the onset of symptoms to diagnosis and treatment. Endometriosis […]
Read moreA joint meeting of the CINDIS project and the MVA Oncology Network Medicon Valley Alliance (MVA) and the Consortium for Intelligent Diagnostics of Skin Cancer (CINDIS) have the pleasure of inviting you to a joint CINDIS Symposium and MVA Oncology Network meeting about non-invasive diagnosis of skin cancers. It is difficult to diagnose skin cancers […]
Read moreIn this seminar two MVA members, TECHNIA and Novo Nordisk, join forces to share more holistic insights about digital trends and tools for sustainable and compliant product creation and warmly welcome you. The Life Sciences industry can create products faster and more efficiently, while ensuring long-term business sustainability and compliancy by understanding trends and taking […]
Read moreThe transition from early (phase 1, expansion cohorts and single-arm phase 2) trials to later phases of clinical development poses several challenges. While many of these challenges are of strategic and financial natures, some usual methodological pitfalls can be addressed in a somewhat systematic fashion. In this presentation, we will explore these pitfalls and attempt […]
Read moreRecent years have seen a resurgence and rapid growth in the field of cell and gene therapies as therapeutic options to treat diverse clinical indications including neuromuscular diseases, ophthalmic disorders, haemophilia, cancers and much more. Designing and executing a complete bioanalytical strategy to support the preclinical and clinical development of cell and gene therapies can […]
Read moreJoin MVA and Catalent at this Boost Seminar focusing on optimizing oral bioavailability and translating formulation advances for clinical success. Oral solid dosage forms remain a preferred option for many pharmaceutical drug developers. However, their successful development and manufacture still present several unique challenges and opportunities. This event brings together pharmaceutical experts to discuss such […]
Read more